Physician profile
Terry Hackworth
NPI 1174895643
$49,157.44
in general payments reported to CMS, 2019-2025
24 companies · $13K in 2025
The $13K reported for 2025 was more than what 99% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,300 · 2022: $6,086 · 2023: $8,416 · 2024: $20K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $31K · Food and Beverage: $7,988 · Travel and Lodging: $3,186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $30,597.50 |
| Food and Beverage | $7,988.12 |
| Travel and Lodging | $3,186.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $29,469.55 | 2021-2025 | Descovy, Yeztugo, Biktarvy |
| Viiv Healthcare Company | $16,509.22 | 2021-2025 | Dovato, Apretude, Cabenuva |
| Merck Sharp & Dohme LLC | $814.98 | 2021-2025 | Pifeltro, Delstrigo, Dificid |
| Emd Serono, INC. | $419.52 | 2021-2025 | Serostim |
| Theratechnologies INC. | $387.44 | 2021-2025 | Trogarzo, Egrifta |
| Abbvie INC. | $316.34 | 2021-2024 | |
| Janssen Biotech, INC. | $241.59 | 2021-2023 | Symtuza |
| Lilly USA, LLC | $239.62 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $212.95 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Abbott Laboratories | $103.74 | 2024-2025 | Freestyle Libre 3 |
| Exact Sciences Corporation | $65.24 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Verity Pharmaceuticals INC. | $62.95 | 2024-2025 | Tlando |
| Antares Pharma, INC. | $55.13 | 2022-2025 | Xyosted, Nocdurna, Tlando |
| Otsuka America Pharmaceutical, INC. | $46.74 | 2023-2024 | Rexulti |
| Napo Pharmaceuticals INC | $37.53 | 2024-2025 | Mytesi |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $32.27 | 2023-2024 | Dexcom G6 Transmitter |
| Csl Behring | $20.76 | 2023 | Hizentra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.47 | 2023 | Xifaxan, Trulance |
| Takeda Pharmaceuticals U.S.A., INC. | $19.86 | 2024 | Trintellix |
| Glaxosmithkline, LLC. | $19.16 | 2023 | Arexvy, Shingrix |
| Halozyme INC | $17.98 | 2023 | |
| Astrazeneca Pharmaceuticals Lp | $15.66 | 2023 | |
| Tolmar, INC. | $15.39 | 2023 | |
| Ferring Pharmaceuticals INC. | $13.35 | 2023 | Rebyota |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terry Hackworth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.